Benchmark Financial Wealth Advisors, LLC Amgen Inc Transaction History
Benchmark Financial Wealth Advisors, LLC
- $264 Million
- Q1 2025
A detailed history of Benchmark Financial Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Benchmark Financial Wealth Advisors, LLC holds 773 shares of AMGN stock, worth $236,986. This represents 0.09% of its overall portfolio holdings.
Number of Shares
773
Previous 770
0.39%
Holding current value
$236,986
Previous $200,000
20.0%
% of portfolio
0.09%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding AMGN
# of Institutions
3,285Shares Held
426MCall Options Held
8.07MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$16.2 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.95 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$5.12 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.98 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $164B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...